Parents
Sign in to add mentorAlexandra C. Newton | grad student | 2002-2007 | UCSD (Chemistry Tree) | |
(PHLPP: A novel family of phosphatases that are critical regulators of intracellular signaling pathways.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Torres-Ayuso P, Katerji M, Mehlich D, et al. (2023) PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chemical Biology |
Torres-Ayuso P, Brognard J. (2022) Degraders: The Ultimate Weapon Against Amplified Driver Kinases in Cancer. Molecular Pharmacology. 101: 191-200 |
Torres-Ayuso P, An E, Nyswaner KM, et al. (2021) TNIK is a therapeutic target in Lung Squamous Cell Carcinoma and regulates FAK activation through Merlin. Cancer Discovery |
Hoang VT, Nyswaner K, Torres-Ayuso P, et al. (2020) The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells. The Journal of Biological Chemistry |
Ayuso PT, An E, Ritt D, et al. (2020) The protein kinase TNIK: a novel druggable target in Lung Squamous Cell Carcinoma with 3q amplification. The Faseb Journal. 34: 1-1 |
Torres-Ayuso P, Brognard J. (2019) Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets. Cancers. 11 |
Prelowska M, Mehlich D, Lazniewski M, et al. (2019) Abstract P3-09-07: The role of MLK4 amplification in progression of triple negative breast cancer Cancer Research |
Marusiak AA, Prelowska MK, Mehlich D, et al. (2018) Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells. Oncogene |
An E, Brognard J. (2018) Orange is the new black: Kinases are the new master regulators of tumor suppression. Iubmb Life |
Torres-Ayuso P, Brognard J. (2018) Shipping Out MEK Inhibitor Resistance with SHP2 Inhibitors. Cancer Discovery. 8: 1210-1212 |